Bronchiectasis Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2024 Update
Powered by
All the vital news, analysis, and commentary curated by our industry experts.
Bronchiectasis Clinical Trial Report Overview
A total of 394 Bronchiectasis clinical trials were conducted as of March 2024. The Bronchiectasis clinical trial report provides a comprehensive understanding of the Bronchiectasis clinical trial scenario across regions, and countries (G7 & E7), along with insights into the various phases, trial status, and end points status. The report also includes information about the sponsor types and the prominent sponsors associated with the trials.
Key Regions | · Asia-Pacific
· Europe · North America · Middle East and Africa · South and Central America |
Key Countries | · China
· United Kingdom · United States · Australia · Spain |
Key Sponsor Types | · Company
· Institution · Government |
Leading Sponsors | · Bayer AG
· Aradigm Corp (Inactive) · AstraZeneca Plc · C. H. Boehringer Sohn AG & Co KG · Novartis AG |
Enquire & Decide | Discover the perfect solution for your business needs. Enquire now and let us help you make an informed decision before making a purchase. |
Bronchiectasis Clinical Trials Segmentation by Regions and Countries
As of March 2024, Asia-Pacific led the Bronchiectasis clinical trials landscape with more than 50% of the clinical trials conducted there
The key regions considered for Bronchiectasis clinical trials analysis are North America, Europe, Asia-Pacific, the Middle East and Africa, and South and Central America.
In the country-wise analysis, China has the highest number of Bronchiectasis clinical trials, as of March 2024. Italy has the highest average patient enrollment in Bronchiectasis clinical trials during the same time.
G7 countries: Among the G7 (United States, United Kingdom, Germany, France, Italy, Canada, and Japan) countries, the United Kingdom had the highest proportion of Bronchiectasis to Respiratory clinical trials as of March 2024.
E7 countries: Among the E7 (Brazil, Russia, India, China, Mexico, Turkey, and Indonesia) countries, China has the highest proportion of Bronchiectasis to Respiratory clinical trials as of March 2024.
Bronchiectasis Clinical Trials Analysis by Regions, 2024 (%)
Buy the Full Report for More Regional Insights into the Bronchiectasis Clinical Trials
Download a Free Sample Report
Bronchiectasis Clinical Trials Segmentation by Sponsor Types
The key sponsor types for Bronchiectasis clinical trials are company, institution, and the government. As of March 2024, more than 55% of Bronchiectasis clinical trials conducted were sponsored by company sponsor type, followed by institution.
Bronchiectasis Clinical Trials Analysis by Sponsor Types, 2024 (%)
Buy the Full Report for More Sponsor Type Insights into the Bronchiectasis Clinical Trials
Bronchiectasis Clinical Trials - Competitive Landscape
In 2024, Bayer AG conducted the highest number of Bronchiectasis clinical trials
A few of the leading sponsors for Bronchiectasis clinical trials are:
- Bayer AG
- Aradigm Corp (Inactive)
- AstraZeneca Plc
- H. Boehringer Sohn AG & Co KG
- Novartis AG
Bronchiectasis Clinical Trials Analysis by Sponsors, 2024 (%)
Buy the Full Report to Know More about the Leading Sponsors of Bronchiectasis Clinical Trials
Segments Covered in the Report
Bronchiectasis Clinical Trials Regional Outlook (2024)
- Asia-Pacific
- Europe
- North America
- Middle East and Africa
- South and Central America
Bronchiectasis Clinical Trials Country Outlook (2024)
- China
- United Kingdom
- United States
- Australia
- Spain
Bronchiectasis Clinical Trials Sponsor Type Outlook (2024)
- Company
- Institution
- Government
Scope
- The report provides a snapshot of the global clinical trials landscape.
- The report provides top-level data related to the clinical trials by region, country (G7 & E7), trial status, trial phase, sponsor type, and endpoint status.
- The report reviews the top companies involved and enlists all trials (trial title, phase, and status) of the company.
- The report provides all the unaccomplished trials (terminated, suspended, and withdrawn) with a reason for accomplishment.
- The report provides enrollment trends for the past five years.
- The report provides the latest news for the past three months.
Reasons to Buy
- Formulate key business strategies with regard to investment.
- Identify prominent locations for conducting clinical trials which saves time and cost.
- Get top-level analysis of the Global Clinical Trials Market which helps in identifying key business opportunities.
- Understand trial count and enrollment trends by country in the global therapeutics market.
- Interpret the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended, or withdrawn) trials.
- Understand clinical trial assessment of the indication on a global, regional, and country level.
Aradigm Corp (Inactive)
AstraZeneca Plc
C. H. Boehringer Sohn AG & Co KG
Novartis AG
Zambon Co SpA
Savara Inc
Chiesi Farmaceutici SpA
Gilead Sciences Inc
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd
Table of Contents
Table
Figures
Frequently asked questions
-
Which region accounted for the highest number of Bronchiectasis clinical trials in March 2024?
Asia-Pacific accounted for the highest number of Bronchiectasis clinical trials as of March 2024.
-
Which country conducted the highest number of Bronchiectasis clinical trials in March 2024?
China conducted the highest number of Bronchiectasis clinical trials as of March 2024.
-
Which sponsor type was the most prominent in the Bronchiectasis clinical trials in March 2024?
As of March 2024, most of the Bronchiectasis clinical trials conducted were sponsored by company sponsor type.
-
Which are the leading sponsors of Bronchiectasis clinical trials?
A few of the leading sponsors of Bronchiectasis clinical trials are Bayer AG, Aradigm Corp (Inactive), AstraZeneca Plc, C. H. Boehringer Sohn AG & Co KG, and Novartis AG among others.
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.